Haisheng Pharmaceutical (300584.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 62.2556 million, up 90.51% year on year.

Zhitong Finance APP News, Haisheng Pharmaceutical (300584.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 615 million yuan, a year-on-year increase of 30.49%; net profit attributable to shareholders of the listed company was 62.2556 million yuan, a year-on-year increase of 90.51%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.6975 million yuan, a year-on-year increase of 125.76%; basic earnings per share were 0.5188 yuan.